Evidence map›Paper›PMID 22465320›Full record

ArticleNeuroscience letters2012

Elucidating the role of 5-HT(1A) and 5-HT(7) receptors on 8-OH-DPAT-induced behavioral recovery after experimental traumatic brain injury.

Narayana K Yelleswarapu, Justin K Tay, William M Fryer, Mansi A Shah, Alexandra N Garcia, Jeffrey P Cheng, Anthony E Kline

Abstract read
In one paragraph

Article in Neuroscience letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Altered Serotonin 2A (5-HTFrontiers in pharmacology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Narayana K YelleswarapuPhysical Medicine & Rehabilitation, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Justin K Tay
William M Fryer
Mansi A Shah
Alexandra N Garcia
Jeffrey P Cheng
Anthony E Kline
University of Pittsburgh · USCenter for the Neural Basis of Cognition · US

Funding

Environmental Enrichment and Cholinergic Mechanisms after TBIR01NS060005 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLINE, ANTHONY E. · 2009 to 2013
$1.6M
Understanding the Impact of Antipsychotic Drugs on Recovery After TBIR01HD069620 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLINE, ANTHONY E. · 2012 to 2016
$1.6M
Novel Rehabilitative Approaches for Recovery from TBIR01HD046700 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLINE, ANTHONY E. · 2005 to 2008
$1.2M
Interaction of Serotonin &Cholinergic Systems After TBIR03HD043851 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLINE, ANTHONY E · 2003 to 2004
$144k
NICHD NIH HHS HD043851NICHD NIH HHS HD046700NICHD NIH HHS R01 HD046700NICHD NIH HHS R01 HD069620NICHD NIH HHS R03 HD043851NINDS NIH HHS NS060005NINDS NIH HHS R01 NS060005
6 · The paper itself

Abstract

8-OH-DPAT is a 5-HT(1A/7) receptor agonist that enhances behavioral recovery after traumatic brain injury (TBI). This study is a first attempt to decipher whether the benefits induced by 8-OH-DPAT after TBI are mediated by 5-HT(1A) or 5-HT(7) receptors. A single i.p. injection of 8-OH-DPAT (0.5 mg/kg) alone or co-administered with either the 5-HT(1A) or 5-HT(7) receptor antagonists WAY 100635 (0.5 mg/kg) or SB 269970 HCl (2.0 mg/kg), respectively, or vehicle control (1.0 mL/kg) was given 15 min after cortical impact or sham injury. Function was assessed by established motor and cognitive tests. No difference in motor performance was observed among the TBI groups. Spatial acquisition was enhanced, relative to vehicle controls, by 8-OH-DPAT alone and when co-administered with WAY 100635, but not when combined with SB 269970 HCl. These data imply that 5-HT(1A) receptor antagonism does not abate the 8-OH-DPAT-induced cognitive benefits, but 5-HT(7) receptor antagonism does, which suggests that the 8-OH-DPAT-induced benefits in this single administration paradigm may be mediated more by 5-HT(7) versus 5-HT(1A) receptors. Evaluation of a specific 5-HT(7) receptor agonist will further elucidate the contribution of 5-HT(1A) and 5-HT(7) receptors on behavioral recovery conferred by acute 8-OH-DPAT treatment after TBI.

Indexed as

8-Hydroxy-2-(di-n-propylamino)tetralinAnimalsBehavior, AnimalBrain InjuriesMaleMaze LearningMotor ActivityPhenolsPiperazinesPyridinesRatsRats, Sprague-DawleyReceptor, Serotonin, 5-HT1AReceptors, SerotoninRecovery of FunctionSerotonin Receptor Agonists8-Hydroxy-2-(di-n-propylamino)tetralinN-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamidePhenolsPiperazinesPyridinesReceptor, Serotonin, 5-HT1AReceptors, SerotoninSB 269970serotonin 7 receptorSerotonin Receptor AgonistsSulfonamides

Identifiers

PMID22465320
PMCPMC3328631
OpenAlexW2077624784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.